This fall marks the first time that vaccines will be available to fight the triple threat of Covid-19, flu and respiratory syncytial virus, or RSV.
Some Massachusetts scientists are at the center of the upcoming vaccine campaigns, with new shots and medicines ready to go for the three respiratory viruses, which pose an increased risk to young children, elderly adults and immunocompromised people.
Moderna Inc. (Nasdaq: MRNA) has updated its Covid vaccine to more closely match currently circulating…
